Ok-Ju Kang

4PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 25, 2026
Clinical significance of circulating tumor DNA monitoring based on TP53 mutation in high-grade serous ovarian cancer patients.

|May 16, 2024
Predictive value of SUVmax from initial 18F-FDG PET/CT scans for treatment outcomes in endometrial cancer patients undergoing fertility sparing management.

Ok-Ju Kang, Yonghee Park, Eun Min Lee

|Aug 04, 2023
Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.

Ok-Ju Kang, Shin-Wha Lee, Ju-Hyun Kim

|Apr 24, 2023
A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancer (KGOG 4011/PBM).

Jeong-Yeol Park, Ok Ju Kang, Yoo-Young Lee

Pageof 1

Frequent Collaborators

2 joint publications

Jeong-Yeol Park

1 joint publications

Yoo-Young Lee

1 joint publications

Young Seok Kim

1 joint publications

Heejung Jung